The present invention relates to an applicator for applying a fluid to a surface. In embodiments, the applicator is useful for applying a medicament-containing fluid to the skin. In particular embodiments, the applicator is useful for applying a topical or transdermal testosterone composition to the skin of a patient in need of testosterone replacement therapy.
It is known from U.S. Pat. No. 8,177,449 to Bayly et al. to provide an implement for applying a volume of liquid containing testosterone to an underarm or axilla skin surface. This implement includes a cylindrical rigid support or handle on which a resiliently deformable thin flexible membrane is mounted. The membrane has a generally circular shape, with an inner circular area or base in contact with, but not secured to, the upper surface of the cylindrical rigid support. The membrane extends upwardly away from the circumference of the fixed inner circular area and is folded over to create an upper folded edge. The membrane then extends back down towards the rigid support, with the outer circumference of the membrane forming a lower outer edge which is fixed in position to the rigid support. With this structure, the secured inner circular area or base, and the upstanding wall, form a reservoir. In operation, a volume of liquid is pumped into the reservoir. The upper folded edge the membrane is then rubbed over the skin surface to which the liquid is to be applied, whereby the upper folded edge spreads the liquid over this skin surface.
However, it has been found that, with the implementation of this patent, the upper folded edge of the membrane tends to deform rather than roll over the skin surface. As a result of this deformation, a seal is difficult to maintain, with some leakage of the liquid from between the implement and the skin surface. In addition, because of this action, underarm hairs tend to be pulled, causing discomfort to the person.
In aspects, the present invention provides an applicator that overcomes the aforementioned problems.
In one aspect, the present invention provides an applicator for applying a fluid to a surface, the applicator comprising:
1) a support comprising an upper outer surface and a lower holding surface;
2) a flexible membrane comprising:
3) a membrane holder for fixedly securing the lower end of the inner wall of the flexible membrane to the upper outer surface of the support; wherein the upper surface of the membrane holder and the inner wall of the flexible membrane define a reservoir for holding a fluid, and wherein the lower end of the outer wall of the flexible membrane is free to move axially relative to the upper outer surface of the support when pressure is applied to the upper folded wall of the flexible membrane.
In another aspect, the present invention provides a kit comprising the disclosed applicator, a dispenser bottle containing a fluid, and a cap adapted to engage the support and cover the flexible membrane.
In another aspect, the present invention provides a method of applying topical or transdermal testosterone composition to the skin of a human in need thereof, the method comprising providing the disclosed applicator, placing the topical or transdermal testosterone composition in the reservoir of the applicator, and applying the topical or transdermal testosterone composition from the reservoir to the skin.
Various embodiments of aspects of the invention are disclosed below. The above and other features of the invention will become readily apparent from the following detailed description thereof which is to be read in connection with the accompanying drawings.
Referring to the drawings in detail, there is shown in
Reference to a “surface” is used herein to include any solid or semi-solid material having one or more areas capable of being contacted with an applicator, such as woods, metals, minerals, ceramics, glasses, plastics, polymers, composite materials, and the like, as well as animal surfaces, such as skin and other organ surfaces. Reference to a “fluid” used herein is intended to include any flowable substance, such as liquids, solutions, foams, lotions, gels, creams, pastes, and the like. Embodiments of the applicator described herein have particular utility in the application of a medicated topical or transdermal fluid containing testosterone to the axilla of a human. In this way, contact of the medicated fluid with the user's hand can be avoided, thereby minimizing unintended interpersonal transfer of testosterone.
Applicator 10 is intended to seat upon the upper end of a bottle 12 containing the fluid, the bottle 12 having a pump dispenser 14 for dispensing the fluid to applicator 10 when applicator 10 is removed from bottle 12. As shown best in
As shown in
Two sets of substantially parallel, spaced-apart ribs 42, 44, 46, 48 and 50 extend continuously along the inner surface of intermediate section 34 from the upper end thereof to a position about one-third of the way down the inner surface of lower section 32, with each set being in opposing relation to the other set and the ribs extending in the direction of the center axis of lower section 32. The inner edges of each rib 42, 44, 46, 48 and 50 extend around a circular area, and each rib faces inwardly along a radius of the circular area. Thus, because the inner surface of lower section 32 has an oval section, outer ribs 42 and 50 extend inwardly to a greater extent than middle ribs 44 and 48, and middle ribs 44 and 48 extend inwardly to a greater extent than the center rib 46. In this manner, when lower section 32 seats on main body 16 of bottle 12, the lower edges of ribs 42, 44, 46, 48 and 50 seat on annular shoulder 22, and the inner edges of ribs 42, 44, 46, 48 and 50 frictionally engage the outer surface of intermediate annular wall 20. In addition, further ribs 52 extend axially down from the lower ends of ribs 42 and to the lower edge of lower section 32, with ribs 52 having very small inward dimensions so as to effectively form small beads. When rigid support 30 is positioned on main body 16 such that ribs 42, 44, 46, 48 and 50 frictionally engage the outer surface of intermediate annular wall 20, ribs 52 function to provide some frictional engagement with the outer wall of main body 16 to prevent wobbling of rigid support 30 on main body 16.
The number of ribs can vary, as desired, for devices of different dimensions and materials of construction.
The outer surface of intermediate section 34 is provided with four equiangularly spaced elongated depressions 35 around a common peripheral line, immediately above shoulder 38, the purpose for which will be understood from the description hereafter.
The upper edge of upper section 36 is closed off by an upper oval shaped top wall 54, and reinforcing ribs 56 connect opposing inner surfaces of upper section 36 and are connected to the inner or lower surface of top wall 54. Vent openings 58 can be provided in top wall 54 between ribs 56. In addition, two guide openings 60 are provided in oval top wall 54 at opposite ends of the longer axis thereof, and a central securing opening 62 is provided along the same longer axis between guide openings 60. Vent openings 58 are provided to opposite sides of this longer axis. Lastly, an upper oval lip 63 extends upwardly, slightly inward from the outer periphery of top wall 54.
As shown best in
From the outer periphery of oval shaped ring 68, membrane 64 continues upwardly along an inner wall section 72, is folded over at its upper end to form an upper folded end 74 and then continues downwardly to form an outer wall section 76. Upper folded end 74 in this embodiment forms a continuous oval shape. However, unlike the lower end of the outer wall section of the implement of U.S. Pat. No. 8,177,449 to Bayly et al., which is fixed to the implement, the lower end 78 of outer wall section 76 according to the present invention is not fixed to support 30, and in fact, is free to move axially relative to upper section 36 during application of a fluid to the surface. As a result, when the user applies membrane 64 to the surface, and pressure is applied to the upper folded end 74, lower end 78 moves distally down upper section 36 towards middle section 34, resulting in little to no lateral deformation of upper folded end 74 against the surface. Rather, upper folded end 74 deforms relatively uniformly around its perimeter along an axis that is transverse to central opening 66, resulting in more of a rolling action, which allows for a tighter seal with the surface. In certain embodiments, a vacuum seal is created. As a result, relatively less leakage of fluid may occur when membrane 64 is moved laterally across the surface. When applied to a skin surface, pulling of hair may be reduced during lateral movement of membrane 64.
As will be appreciated from the discussion hereafter, lower end 78 is thickened with the same material, to form an oval shaped lip 77 extending inwardly from lower end 78, with lip 77 having a generally square or rectangular cross-section, and with opposite nubs 79 extending upwardly in an axial direction at an upper surface of lip 77 at the inner periphery thereof, along the long axis of the oval shape of lip 77.
Oval shaped ring 68 is fixed to the upper surface of oval shaped top wall 54 by a membrane holder 80, which is best shown in
With this structure, after membrane 64 is positioned on rigid support 30 by positioning oval lip 67 on top wall 54 and within the confines of upper oval lip 63 thereof, membrane holder 80 is positioned on top of ring 68 such that downturned lip 84 at the outer periphery thereof sits on ring 68, and downturned wall 86 fits within the confines of ring 68. At the same time, nubs 70 of membrane fit within cut-outs 98. In this regard, nubs 70 and cut-outs 98 form first and second alignment elements, respectively.
At the same time, guide pins 96 fit through guide openings 60, and central boss 94 fits through central securing opening 62. Thereafter, a securement member 100 is threadedly screwed from below into internal opening 95 of central boss 94 to fixedly secure ring 68 to top wall 54 in a fluid sealing manner.
A reservoir 103 for holding a fluid is thereby defined by the upper surface of plate 82 of membrane holder (which now covers and closes central opening 66 of membrane 64) and the inner wall section 72 of membrane 64 extending upwardly therefrom. Where a medicated fluid is to be applied to skin, plate 82 is preferably made of a material that is compatible with the medicated fluid (e.g., does not leach) and is safe for contact with skin.
At this time, outer wall section 76 of membrane is positioned in surrounding relation to upper section 36 with the lower end 78 thereof being free and movable in the axial direction of upper section 36.
In order to better provide for controlled free sliding movement of lower end 78 of outer wall section 76, in a preferred embodiment best shown in
Skirt 102 is formed by an upper oval plate 104 and a lower oval plate 106 connected together in parallel, spaced apart relation by a plurality of equiangularly spaced connecting walls 108 connected at inner edges of plates 104 and 106. Thus, an oval recess 110 is defined by plates 104 and 106, and connecting walls 108. In addition, upper wall includes two small openings 112 at the outer edge thereof in opposing relation to each other along the long axis of the oval shape of skirt 102. Accordingly, oval shaped lip 77 of membrane 64 fits within oval recess 110 and is retained therein. At the same time, nubs 79 of membrane 64 fit within small openings 112.
Lastly, when not in use, a cap 114 is provided for covering membrane 64. Specifically, as best shown in
A kit can be provided comprising applicator 10, bottle 12 and cap 114. In operation, when used to apply a fluid to a skin surface, applicator 10 is removed from bottle 12 and cap 114 is removed from intermediate section 34. Thereafter, a dose of fluid from bottle 12 is pumped into reservoir 103 by pump 28. Holding support 30, upper folded end 74 of membrane 64 is then placed in contact with the skin surface, causing lower end 78 to move distally down upper section 36 of support 30 towards middle section 34, thereby creating a seal (preferably a vacuum) between membrane 64 and the skin surface. Upper folded end 74 may then be moved across the skin surface by the user until the desired amount of fluid has been applied from the reservoir to the skin.
If the fluid contains a medicament, reservoir 103 can be washed after use to reduce the likelihood of interpersonal transfer of the medicament. The medicated fluid can contain any physiologically active agent which can be delivered to the skin to achieve a desired effect. Thus, the applicator may be used to apply drugs, vitamins, cosmetics, sunscreens, and the like. The medicated fluid may also contain one or more inactive agents, including any one or more of carriers, thickening agents, volatile agents, penetration enhancers, pH adjusting agents, preservatives, surfactants, occlusive agents, emulsifiers, colorants, and the like.
In a particular embodiment, applicator 10 is used to apply a topical or transdermal testosterone composition to the skin of a human in need thereof. Any composition capable of delivering testosterone through the skin can be used and are well known in the art. Any condition can be treated wherein an increase in blood testosterone levels is desired. In an embodiment, the topical or transdermal testosterone composition is applied to one or more axilla of a male in need of testosterone replacement therapy. Conditions associated with deficiency or absence of endogenous testosterone amenable to treatment with a liquid testosterone composition include primary hypogonadism (congenital or acquired), including testicular failure due to conditions such as cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome, orchiectomy, Klinefelter's syndrome, chemotherapy, or toxic damage from alcohol or heavy metals, and hypogonadotropic hypogonadism (congenital or acquired), including idiopathic gonadotropin or luteinizing hormone-releasing hormone (LHRH) deficiency or pituitary-hypothalamic injury from tumors, trauma, or radiation. The topical or transdermal testosterone composition is preferably capable of maintaining serum testosterone concentrations in the normal range (i.e., approximately 300 ng/dL to about 1050 ng/dL) following one or more applications.
Referring now to
As shown best in
Thin downwardly extending wall 268 is fixedly secured to the outer peripheral surface of a membrane or diaphragm holder 280, and particularly, to the outer peripheral surface of a generally oval shaped ring 282 thereof by an adhesive so as to provide a sealing fit therewith. A long rib 290 extends between opposite sides of oval ring 282 along the long axis thereof and a short rib 292 extends between opposite sides of oval ring 282 along the short axis thereof. In addition, other transverse ribs 293 extend in parallel, spaced apart relation to short rib 292 between opposite sides of oval ring 282. A top wall 295 closes the upper end of oval shaped ring 282, and all ribs 290, 292 and 293 are also connected to top wall 295. Central boss 94 of the first embodiment is eliminated. Two guide pins 296 extend down from opposite ends of long rib 290 at the connection of ribs 290 and 293.
In addition, as shown best in
In order to better provide for controlled free sliding movement of lower end 278 of outer wall section 276, in a preferred embodiment best shown in
The operation of the modified applicator 210 is the same as the first applicator 10 described above.
It will be appreciated that modifications to the present invention can be made to the scope of the present invention as defined by the appended claims. Thus, for example, while many parts have been described as having an oval shape, the present invention is not limited thereby, and any other suitable shape can be used. In particular, generally circular, square, and rectangular shapes are useful.
Having described certain specific aspects and embodiments of the invention with reference to the accompanying drawings, it will be appreciated that the present invention is not limited to those precise embodiments and that various changes and modifications can be effected therein by one of ordinary skill in the art without departing from the scope or spirit of the invention as defined by the appended claims.
This application is a continuation of and claims the benefit of priority of pending U.S. application Ser. No. 14/100,817, filed on Dec. 9, 2013. The foregoing application and all documents cited therein are hereby incorporated herein by reference in their entireties.
Number | Name | Date | Kind |
---|---|---|---|
4726700 | Gray | Feb 1988 | A |
5904151 | Gueret | May 1999 | A |
6299900 | Reed et al. | Oct 2001 | B1 |
6309128 | Griebel et al. | Oct 2001 | B1 |
6773187 | Gueret | Aug 2004 | B2 |
6818226 | Reed et al. | Nov 2004 | B2 |
6923983 | Morgan et al. | Aug 2005 | B2 |
6945723 | Gueret | Sep 2005 | B1 |
6981814 | Geardino et al. | Jan 2006 | B2 |
7381005 | Altonen et al. | Jun 2008 | B2 |
7927034 | Staniforth et al. | Apr 2011 | B2 |
8071075 | Reed et al. | Dec 2011 | B2 |
8177449 | Bayly | May 2012 | B2 |
8419307 | Bayly et al. | Apr 2013 | B2 |
8435944 | Dipietro et al. | May 2013 | B2 |
8469621 | Zukowski et al. | Jun 2013 | B2 |
9827407 | Carrara | Nov 2017 | B2 |
20040047674 | Geardino et al. | Mar 2004 | A1 |
20050054991 | Tobyn et al. | Mar 2005 | A1 |
20070189841 | Gueret | Aug 2007 | A1 |
20070206987 | Phipps | Sep 2007 | A1 |
20070293842 | Knight et al. | Dec 2007 | A1 |
20100217176 | Carrara et al. | Aug 2010 | A1 |
20110110702 | Song | May 2011 | A1 |
20120074176 | Sullivan et al. | Mar 2012 | A1 |
20120220959 | Bayly et al. | Aug 2012 | A1 |
20120259277 | Shay et al. | Oct 2012 | A1 |
20140221945 | Dos Santos et al. | Aug 2014 | A1 |
20140270897 | Laurusonis | Sep 2014 | A1 |
20150045702 | Lin | Feb 2015 | A1 |
Number | Date | Country |
---|---|---|
WO-9964313 | Dec 1999 | WO |
2006005135 | Jan 2006 | WO |
WO-2013000778 | Jan 2013 | WO |
Entry |
---|
Extended European Search Report in Appln. No. 14868970.6 dated Aug. 2, 2017, 8 pages. |
Highlights of Prescribing Information for Axiron (testerone) topical solution, for topical use CIII, 17 pages. |
PCT International Search Report and Written Opinion in PCT/US2014/068296, dated Mar. 20, 2015, 14 pages. |
TM Reg. No. 4,277,418, Registered Jan. 15, 2013, 2 pages. |
International Preliminary Report of Patentability in PCT/US2014/068296, dated Jun. 23, 2016, 9 pgs. |
Number | Date | Country | |
---|---|---|---|
20160082237 A1 | Mar 2016 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14100817 | Dec 2013 | US |
Child | 14956507 | US |